Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma
Authors
Keywords
Salivary duct carcinoma, Androgen receptor, HER2, Ki-67, EGFR
Journal
International Journal of Clinical Oncology
Volume 20, Issue 1, Pages 35-44
Publisher
Springer Nature
Online
2014-02-19
DOI
10.1007/s10147-014-0674-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunohistochemical Analysis of Salivary Gland Tumors: Application for Surgical Pathology Practice
- (2012) Toshitaka Nagao et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Biology and Management of Salivary Gland Cancers
- (2012) David J. Adelstein et al. SEMINARS IN RADIATION ONCOLOGY
- Systemic therapy in the management of metastatic or advanced salivary gland cancers
- (2012) Aymen Lagha et al. Head and Neck Optical Diagnostics Society
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options
- (2011) Heidy C.J. Jaspers et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review
- (2011) Orit Kaidar-Person et al. MEDICAL ONCOLOGY
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
- (2010) Isabella Castellano et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance
- (2010) M. D. Williams et al. CLINICAL CANCER RESEARCH
- Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
- (2010) T. Tanei et al. EJSO
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer
- (2008) Bhavna Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
- Biological therapy of salivary duct carcinoma
- (2008) M Nashed et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
- (2008) L.D. Locati et al. ORAL ONCOLOGY
- Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy
- (2007) Aleix Prat et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started